2500 — Venus Medtech (Hangzhou) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Venus Medtech (Hangzhou), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,955	1,879	782	306	264
Net Total Accounts Receivable
Net Total Receivables	356	384	455	362	210
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,440	2,469	1,608	802	667
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	262	472	700	524	116
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	5,109	5,283	4,414	3,250	2,519
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	209	492	805	362	241
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	564	1,675	1,493	1,039	757
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	4,546	3,608	2,921	2,211	1,763
Total Liabilities & Shareholders' Equity	5,109	5,283	4,414	3,250	2,519
Total Common Shares Outstanding